Lv4
520 积分 2022-08-30 加入
Long-Term Effectiveness and Safety of Denosumab for Osteoporosis in Patients With Rheumatic Diseases
1个月前
已关闭
A randomized, phase II trial of fulvestrant or exemestane with or without ribociclib after progression on anti-estrogen therapy plus cyclin-dependent kinase 4/6 inhibition (CDK 4/6i) in patients (pts) with unresectable or hormone receptor–positive (HR+), HER2-negative metastatic breast cancer (MBC): MAINTAIN trial
3个月前
已关闭
A randomized, phase II trial of fulvestrant or exemestane with or without ribociclib after progression on anti-estrogen therapy plus cyclin-dependent kinase 4/6 inhibition (CDK 4/6i) in patients (pts) with unresectable or hormone receptor–positive (HR+), HER2-negative metastatic breast cancer (MBC): MAINTAIN trial
3个月前
已关闭
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial
3个月前
已完结
Elacestrant in ER+, HER2− Metastatic Breast Cancer with ESR1 -Mutated Tumors: Subgroup Analyses from the Phase III EMERALD Trial by Prior Duration of Endocrine Therapy plus CDK4/6 Inhibitor and in Clinical Subgroups
3个月前
已完结
Disitamab Vedotin: First Approval
4个月前
已完结
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2025 edition)]
5个月前
已完结
Current status and future outlooks on therapeutic drug monitoring of fluorouracil
5个月前
已完结
Influence of methylene tetrahydrofolate reductase C667T gene polymorphism on survival time of adanced gastric cancer patients treated with 5-fluorouracil-based chemotherapy
5个月前
已完结
皖公网安备34019202002308
